Subependymal giant cell astrocytoma epidemiology and demographics

Subependymal giant cell astrocytoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subependymal giant cell astrocytoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subependymal giant cell astrocytoma epidemiology and demographics
CDC on Subependymal giant cell astrocytoma epidemiology and demographics
Subependymal giant cell astrocytoma epidemiology and demographics in the news
Blogs on Subependymal giant cell astrocytoma epidemiology and demographics
Directions to Hospitals Treating Ependymoma
Risk calculators and risk factors for Subependymal giant cell astrocytoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Prevalence

• There have been 110 reported cases of subependymal giant cell astrocytomas in the literature.
• The prevalence of subependymal giant cell astrocytoma is estimated to be 110 cases in total.

Reference

Template:WikiDoc Sources